É. Weltgesundheitsorganisation, Therapeutic patient education: continuing education programmes for health care providers in the field of prevention of chronic diseases ; report of a WHO working group, 1998.

P. G. Gibson, Limited (information only) patient education programs for adults with asthma, Cochrane Database Syst. Rev, vol.151, issue.6, p.1005, 2002.
DOI : 10.1136/bmj.308.6944.1591

G. Candelas, V. Villaverde, S. García, M. Guerra, M. J. León et al., Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: A systematic literature review, Rheumatology International, vol.71, issue.11, pp.1493-1506
DOI : 10.1136/annrheumdis-2011-200185

R. I. Horwitz, Treatment adherence and risk of death after a myocardial infarction, The Lancet, vol.336, issue.8714, pp.542-545, 1990.
DOI : 10.1016/0140-6736(90)92095-Y

D. T. Lau and D. P. Nau, Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes, Diabetes Care, vol.27, issue.9, pp.2149-2153, 2004.
DOI : 10.2337/diacare.27.9.2149

URL : http://care.diabetesjournals.org/content/diacare/27/9/2149.full.pdf

D. A. Hughes, A. Bagust, A. Haycox, and E. T. Walley, The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature, Health Economics, vol.283, issue.7, pp.601-615, 2001.
DOI : 10.1002/047084633X.ch3

R. B. Haynes, D. W. Taylor, D. L. Sackett, E. S. Gibson, C. D. Bernholz et al., « Can simple clinical measurements detect patient noncompliance? », Hypertens, pp.757-764, 1979.
DOI : 10.1161/01.hyp.2.6.757

URL : http://hyper.ahajournals.org/content/hypertensionaha/2/6/757.full.pdf

R. B. Haynes, K. A. Mckibbon, and E. R. Kanani, « Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications, Lancet Lond. Engl, vol.348, pp.9024-383, 1996.

E. A. Grimaldi, . Masson, and . Si, histoire de l'éducation thérapeutique du patient m'était contée? », EM- Consulte, mai-2017. [En ligne]. Disponible sur: http://www.em-consulte.com/article/1123672/article/si-l- histoire-de-l-education-therapeutique-du-pati, pp.16-2017

«. Guide and H. , Structuration d'un programme d'éducation thérapeutique du patient dans les champ des maladies chroniques, 2007.

L. V. Miller and J. Goldstein, More Efficient Care of Diabetic Patients in a County-Hospital Setting, New England Journal of Medicine, vol.286, issue.26, pp.1388-1391, 1972.
DOI : 10.1056/NEJM197206292862605

J. P. Assal, A. Albeanu, B. Peter-riesch, and E. J. Vaucher, « [Cost of training a diabetes mellitus patient. Effects on the prevention of amputation], Diabete Metab, vol.19, 1993.

S. L. Norris, J. Lau, S. J. Smith, C. H. Schmid, and M. M. Engelgau, Self-Management Education for Adults With Type 2 Diabetes: A meta-analysis of the effect on glycemic control, Diabetes Care, vol.25, issue.7, pp.1159-1171, 2002.
DOI : 10.2337/diacare.25.7.1159

J. P. Assal and . Cost, Cost-Effectiveness of Diabetes Education, PharmacoEconomics, vol.8, issue.Supplement 1, pp.68-71, 1995.
DOI : 10.2165/00019053-199500081-00015

J. J. Gagliardino, Patients??? education, and its impact on care outcomes, resource consumption and working conditions: Data from the International Diabetes Management Practices Study (IDMPS), Diabetes & Metabolism, vol.38, issue.2, pp.128-134
DOI : 10.1016/j.diabet.2011.09.002

D. A. Wood, Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial, The Lancet, vol.371, issue.9629, p.9629, 2008.
DOI : 10.1016/S0140-6736(08)60868-5

E. Bruckert, « Effect of an educational program (PEGASE) on cardiovascular risk in hypercholesterolaemic patients », Cardiovasc, Drugs Ther, vol.22, issue.6, pp.495-505, 2008.

P. Giannuzzi, Global Secondary Prevention Strategies to Limit Event Recurrence After Myocardial Infarction, Archives of Internal Medicine, vol.168, issue.20, p.20, 2008.
DOI : 10.1001/archinte.168.20.2194

URL : http://archinte.jamanetwork.com/data/journals/intemed/5723/ioi80123_2194_2204.pdf

P. Jourdain and Y. Juillière, Steering and Working Group Committee Members of the French Task Force on Therapeutic Education in Heart Failure, « Therapeutic education in patients with chronic heart failure: proposal for a multiprofessional structured programme, by a French Task Force under the auspices of the French Society of Cardiology, Arch. Cardiovasc. Dis, vol.104, issue.3, pp.189-201, 2011.

B. Pavy, Therapeutic education in coronary heart disease: Position paper from the Working Group of Exercise Rehabilitation and Sport (GERS) and the Therapeutic Education Commission of the French Society of Cardiology, Archives of Cardiovascular Diseases, vol.106, issue.12, pp.12-680
DOI : 10.1016/j.acvd.2013.10.002

S. Fredericks and T. Yau, Clinical effectiveness of individual patient education in heart surgery patients: A systematic review and meta-analysis, International Journal of Nursing Studies, vol.65, pp.44-53
DOI : 10.1016/j.ijnurstu.2016.11.001

N. Thiriat, I. Peyron, S. Bernard-charrière, A. Monti, S. Pariel et al., « [Therapeutic education of elderly patients under antivitamin -K treatment: evaluation of the program after 5 years], J. Pharm. Belg, issue.3, pp.30-37, 2014.

G. Pernod, EDUC???AVK: Reduction of Oral Anticoagulant-related Adverse Events After Patient Education: A Prospective Multicenter Open Randomized Study, Journal of General Internal Medicine, vol.40, issue.9, pp.1441-1446, 2008.
DOI : 10.7326/0003-4819-133-9-200011070-00010

URL : https://hal.archives-ouvertes.fr/hal-00291806

S. L. Janson, J. V. Fahy, J. K. Covington, S. M. Paul, W. M. Gold et al., Effects of individual self-management education on clinical, biological, and adherence outcomes in asthma, The American Journal of Medicine, vol.115, issue.8, pp.620-626, 2003.
DOI : 10.1016/j.amjmed.2003.07.008

M. A. De-oliveira, S. M. Faresin, V. F. Bruno, A. R. De-bittencourt, and E. A. Fernandes, Evaluation of an educational programme for socially deprived asthma patients, European Respiratory Journal, vol.14, issue.4, pp.908-914, 1999.
DOI : 10.1034/j.1399-3003.1999.14d30.x

M. Rasulnia, Assessing the impact of a remote digital coaching engagement program on patient-reported outcomes in asthma, Journal of Asthma, p.0, 2017.
DOI : 10.2196/jmir.2640

D. Casey, The effectiveness of a structured education pulmonary rehabilitation programme for improving the health status of people with moderate and severe chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trial, Thorax, vol.101, issue.(4), pp.922-928
DOI : 10.1016/j.rmed.2007.04.007

A. C. Collier, A Randomized Study of Serial Telephone Call Support to Increase Adherence and Thereby Improve Virologic Outcome in Persons Initiating Antiretroviral Therapy, The Journal of Infectious Diseases, vol.192, issue.8, pp.1398-1406, 2005.
DOI : 10.1086/466526

E. M. Gardner, Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance, AIDS, vol.22, issue.1, pp.75-82, 2008.
DOI : 10.1097/QAD.0b013e3282f366ff

URL : http://pdfs.journals.lww.com/aidsonline/2008/01020/Differential_adherence_to_combination.9.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1503688753515;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdN2ziiHhY6wPF9tfA80junhqv52ZN6j+QsFNQ3smQ1Ws=;hash|zrenDrD8k3AdqMyvuq2Wiw==

M. O. Johnson, T. B. Neilands, S. E. Dilworth, S. F. Morin, R. H. Remien et al., The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES), Journal of Behavioral Medicine, vol.36, issue.5, pp.359-370, 2007.
DOI : 10.1097/00126334-200207010-00003

C. Healton, S. Taylor, C. Burr, A. Dumois, N. Loewenstein et al., « The impact of patient education about the effect of zidovudine on HIV perinatal transmission: knowledge gain, attitudes, and behavioral intent among women with and at risk of HIV, Am. J. Prev. Med, vol.12, issue.4, pp.47-52, 1996.

N. Marie, T. Luckett, P. M. Davidson, M. Lovell, and E. S. Lal, « Optimal patient education for cancer pain: a systematic review and theory-based meta-analysis », Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.21, pp.12-3529

D. Larrey, Education by a Nurse Increases Response of Patients With Chronic Hepatitis C to Therapy With Peginterferon-??2a and Ribavirin, Clinical Gastroenterology and Hepatology, vol.9, issue.9, pp.781-785, 2011.
DOI : 10.1016/j.cgh.2011.05.022

. Protocol-dominique-larrey and . An, of the treatment by peginterferon alpha 2 ? ribavirin bitherapy in chronic hepatitis C: the PEGOBS Protocol Dominique Larrey (dom-larrey@chu-montpellier.fr) Service d'hépatogastroentérologie et transplantation, 2012.

P. Cacoub, Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study, World Journal of Gastroenterology, vol.14, issue.40, pp.40-6195, 2008.
DOI : 10.3748/wjg.14.6195

C. Renou, P. Lahmek, and A. Pariente, Impact of therapeutic education on the outcome of chronic hepatitis C treatment, 2009.

M. Galindo-rubio, M. J. Morató, E. Menéndez-torre, D. Et-en-nombre-del-grupo, and . España, Therapeutic education and self-care: Results from the cross-sectional study Diabetes, Attitudes, Wishes and Needs 2 (DAWN2) in Spain, Endocrinolog??a y Nutrici??n (English Edition), vol.62, issue.8, pp.391-399, 2015.
DOI : 10.1016/j.endoen.2015.10.008

J. Bernard-leclerc, O. Conort, and Y. Bacq, Impact d???un programme d?????ducation th??rapeutique sur les connaissances, l???observance et la satisfaction des patients trait??s pour h??patite chronique virale C, Education Th??rapeutique du Patient - Therapeutic Patient Education, vol.64, issue.3, pp.21-33, 2011.
DOI : 10.2146/ajhp070074

S. Vaux, C. Pioche, C. Brouard, J. Pillonel, V. Bousquet et al., Maladies infectieuses / Rapports et synthèses; Saint-Maurice : Santé publique France Disponible sur: http://invs.santepubliquefrance.fr/Publications-et-outils/Rapports-et-syntheses/Maladies- infectieuses, pp.9-2017, 2017.

S. Zakhari and . Bermuda, Bermuda Triangle for the liver: Alcohol, obesity, and viral hepatitis, Journal of Gastroenterology and Hepatology, vol.57, issue.Suppl. 1, pp.18-25, 2013.
DOI : 10.1016/j.jhep.2012.03.024

URL : http://onlinelibrary.wiley.com/doi/10.1111/jgh.12207/pdf

Y. Huang, Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study, Hepatology, vol.39, issue.3, pp.807-814, 2014.
DOI : 10.1016/S0168-8278(03)00456-2

L. Elkrief, Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C, Hepatology, vol.27, issue.3, pp.823-831, 2014.
DOI : 10.1111/j.1572-0241.2006.00649.x

Y. Chen, X. Wang, J. Wang, Z. Yan, and E. J. Luo, Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies, European Journal of Cancer, vol.48, issue.14, pp.14-2137, 1990.
DOI : 10.1016/j.ejca.2012.02.063

J. C. Hsiang, E. J. Gane, W. W. Bai, and S. J. Gerred, Type 2 diabetes: A risk factor for liver mortality and complications in hepatitis B cirrhosis patients, Journal of Gastroenterology and Hepatology, vol.20, issue.Suppl. 1, pp.591-599, 2015.
DOI : 10.1586/egh.10.56

C. Lin, Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis, Journal of Hepatology, vol.58, issue.4, pp.730-735
DOI : 10.1016/j.jhep.2012.11.045

P. Marcellin, Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study, The Lancet, vol.381, issue.9865, pp.9865-468
DOI : 10.1016/S0140-6736(12)61425-1

M. Yuen, Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B, Journal of Hepatology, vol.50, issue.1, pp.80-88, 2009.
DOI : 10.1016/j.jhep.2008.07.023

P. Marcellin, Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption, Journal of Hepatology, vol.48, issue.2, pp.200-207, 2008.
DOI : 10.1016/j.jhep.2007.09.010

URL : https://hal.archives-ouvertes.fr/inserm-00324950

A. Septfons, ); Bul Epidemio, Prévalence, morbidité et mrotalité associées aux hépatites Bet C chroniques dans la population hospitalisée en France, 2004.

J. Trinchet, Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort), Hepatology, vol.55, issue.2 Suppl 1, pp.737-750, 2015.
DOI : 10.1002/hep.24794

URL : https://hal.archives-ouvertes.fr/hal-01201948

C. Guarner, Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels, Gastroenterology, vol.117, issue.2, pp.414-419, 1999.
DOI : 10.1053/gast.1999.0029900414

E. Lawitz, Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection, New England Journal of Medicine, vol.368, issue.20, pp.20-1878, 2013.
DOI : 10.1056/NEJMoa1214853

M. Charlton, Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease, Gastroenterology, vol.149, issue.3, pp.649-659, 2015.
DOI : 10.1053/j.gastro.2015.05.010

T. Asselah, Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial, The Lancet Gastroenterology & Hepatology, vol.1, issue.1, pp.25-35, 2016.
DOI : 10.1016/S2468-1253(16)30001-2

C. Hézode, « Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme », Liver Int, 2017.

A. and «. Recommandations, AFEF sur la prise en charge de l'hépatite virale C », mars, 2017.

C. K. Wong, W. C. Wong, E. Y. Wan, A. K. Chan, F. W. Chan et al., Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP), Endocrine, vol.309, issue.21, pp.412-422, 2016.
DOI : 10.1001/jama.2013.4851

«. Has, Surveillance des malades atteints de cirrhose non compliquée et prévention primaire des complications », sept, 2007.

B. Cadier, Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States, Hepatology, vol.27, issue.4, pp.1237-1248
DOI : 10.1016/j.bpg.2013.08.021

I. Rosa, 585 A FRENCH MULTICENTRIC LONGITUDINAL DESCRIPTIVE STUDY OF HEPATOCELLULAR CARCINOMA MANAGEMENT (THE CHANGH COHORT): PRELIMINARY RESULTS, PRELIMINARY RESULTS, pp.231-232, 2010.
DOI : 10.1016/S0168-8278(10)60587-9

A. Madame-le-docteur-marie-noëlle and . Hilleret, Un grand merci de m'avoir confié ce sujet de thèse original et d'avoir accepté avec entrain d'encadrer ma thèse ! Merci de m'avoir fait découvrir et approfondir la thématique de l'éducation thérapeutique

. Merci-pour-ta-grande-disponibilité, que ce soit pour la vie de l'interne ou les projets professionnels personnels et merci pour ta convivialité

P. Au-professeur and . Nahon, coordinateur de la cohorte CIRVIR, sans qui ce travail n'aurait pas pu être réalisé